Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Equity Commonwealth | EQC | Apr 16, 2025 | 1.59 | 0.00 |
Equity Income Wisdomtree | DHS | Apr 16, 2025 | 90.51 | -0.92 |
Equity Lifestyle Properties | ELS | Apr 16, 2025 | 64.92 | -0.87 |
Equity Residential | EQR | Apr 16, 2025 | 67.05 | +0.04 |
Equus Total Return | EQS | Apr 16, 2025 | 1.03 | +13.19 |
EQV Ventures Acquisition | EQV | Apr 16, 2025 | 10.09 | +0.10 |
Erasca | ERAS | Apr 16, 2025 | 1.17 | -1.68 |
Erayak Power Solution Group A | RAYA | Apr 16, 2025 | 1.70 | +3.03 |
Ericsson B ADR | ERIC | Apr 16, 2025 | 7.94 | -1.61 |
Erie Indemnity A | ERIE | Apr 16, 2025 | 411.88 | -1.87 |
Ermenegildo Zegna N.V. | ZGN | Apr 16, 2025 | 6.86 | +0.15 |
Ernexa Therapeutics | ERNA | Apr 16, 2025 | 0.18 | -8.24 |
Ero Copper | ERO | Apr 16, 2025 | 10.93 | +4.00 |
ESAB | ESAB | Apr 16, 2025 | 113.49 | -1.78 |
Escalade | ESCA | Apr 16, 2025 | 14.82 | +1.86 |
Esco Technologies | ESE | Apr 16, 2025 | 150.83 | -1.29 |
ESGL | ESGL | Apr 16, 2025 | 1.85 | -1.60 |
ESH Acquisition | ESHA | Apr 16, 2025 | 11.00 | 0.00 |
Eshallgo | EHGO | Apr 16, 2025 | 1.07 | 0.00 |
Esperion Therapeutics | ESPR | Apr 16, 2025 | 0.96 | -3.19 |
Espey Mfg & Electronics | ESP | Apr 16, 2025 | 30.28 | +3.58 |
Esquire Financial | ESQ | Apr 16, 2025 | 79.51 | +0.85 |
ESS Tech | GWH | Apr 16, 2025 | 2.21 | -4.33 |
ESSA Bancorp | ESSA | Apr 16, 2025 | 17.63 | +1.21 |
ESSA Pharma | EPIX | Apr 16, 2025 | 1.77 | +8.59 |
Essent Group | ESNT | Apr 16, 2025 | 54.63 | -1.97 |
Essential Properties Realty Trust | EPRT | Apr 16, 2025 | 31.87 | +1.24 |
Essential Utilities | WTRG | Apr 16, 2025 | 40.05 | +0.35 |
Essex Property Trust | ESS | Apr 16, 2025 | 271.90 | -0.55 |
Establishment Labs | ESTA | Apr 16, 2025 | 30.18 | -4.08 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.